These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 310897)

  • 1. Antinuclear antibodies in the diagnosis of systemic lupus erythematosus.
    Brandstetter RD
    JAMA; 1979 Feb; 241(8):792. PubMed ID: 310897
    [No Abstract]   [Full Text] [Related]  

  • 2. Lupus erythematosus cell preparation-antinuclear factor incongruity. A review of diagnostic tests for systemic lupus erythematosus.
    Koller SR; Johnston CL; Moncure CW
    Am J Clin Pathol; 1976 Sep; 66(3):495-505. PubMed ID: 60880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic lupus erythematosus and antinuclear factors].
    Le Gô A; Amor B; Kahan A
    Biol Med (1971); 1973 Apr; 2(1):33-50. PubMed ID: 4620250
    [No Abstract]   [Full Text] [Related]  

  • 4. [Detection of antinuclear antibodies in patients with systemic lupus erythematosus by the indirect immunofluorescence test].
    Wierzchowiecki M
    Pol Arch Med Wewn; 1973 Nov; 50(11):1227-35. PubMed ID: 4588504
    [No Abstract]   [Full Text] [Related]  

  • 5. Class specific antinuclear antibodies in systemic lupus erythematosus.
    Savitri K; Sehgal S; Datta BN; Chugh KS
    Indian J Med Res; 1993 Feb; 98():27-9. PubMed ID: 8495986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in systemic lupus erythematosus.
    Amin SN; Maddison PJ
    J Assoc Physicians India; 1989 Aug; 37(8):529-31. PubMed ID: 2695515
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of antinuclear antibodies in systemic lupus erythematosus].
    Stefanović Z; Mijailović B
    Vojnosanit Pregl; 1986; 43(1):16-21. PubMed ID: 3515753
    [No Abstract]   [Full Text] [Related]  

  • 8. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.
    Jearn LH; Kim DA; Kim TY
    J Rheumatol; 2009 Aug; 36(8):1833-4. PubMed ID: 19671822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antinuclear factors in systemic lupus erythematosus].
    Cossermelli W; Gomide WS; Pastor EM; Belliboni N; de Almeida TV
    AMB Rev Assoc Med Bras; 1978 Dec; 24(12):421-3. PubMed ID: 85319
    [No Abstract]   [Full Text] [Related]  

  • 10. Antinuclear antibody-negative systemic lupus erythematosus: revisited.
    Kaur S; Thami GP
    Indian J Pediatr; 2003 Feb; 70(2):185-6. PubMed ID: 12661819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FPIN’s clinical inquiries: antibody testing for systemic lupus erythematosus.
    Gibson K; Goodemote P; Johnson S
    Am Fam Physician; 2011 Dec; 84(12):1407-9. PubMed ID: 22230277
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis of lupus erythematosus].
    Gschnait F; Brenner W; Holubar K
    Hautarzt; 1979 Dec; 30(12):646-50. PubMed ID: 317653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-immunological aspects of antinuclear antibodies in systemic lupus erythematosus].
    Speranskiĭ AI; Aroian AA; Ivanova SM; Panasiuk AF; Riazantseva TA
    Revmatologiia (Mosk); 1987; (3):28-34. PubMed ID: 2446367
    [No Abstract]   [Full Text] [Related]  

  • 14. Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis.
    Blaustein DA; Blaustein SA
    J Rheumatol; 1998 Apr; 25(4):798-800. PubMed ID: 9558189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between organic changes, antibodies against native DNA and antinuclear antibody titer in patients with systemic lupus erythematosus].
    Marczak M; Kardaszewicz E
    Pol Tyg Lek; 1985 Jun; 40(23):654-6. PubMed ID: 3876550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differential diagnosis of initial manifestations of systemic lupus erythematosus].
    Schwick N; Schmitz S; Dellanna F; Neveling M; Gheorghiu T
    Med Klin (Munich); 1993 Feb; 88(2):85-7. PubMed ID: 8450814
    [No Abstract]   [Full Text] [Related]  

  • 17. Antinuclear and anticytoplasmic antibodies in lupus erythematosus.
    Kulick KB; Reichlin M
    Clin Dermatol; 1985; 3(3):4-19. PubMed ID: 3916827
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlation of Sm antibodies and clinical symptoms in systemic lupus erythematosus].
    Serfling U; Brenke A; Ziegler H; Barthelmes H; Sönnichsen N
    Dermatol Monatsschr; 1988; 174(11):667-70. PubMed ID: 3264793
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlation between the presence of antibodies to native DNA and the occurrence of the LE phenomenon in patients with visceral lupus erythematosus].
    Marczak M; Kardaszewicz E; Sikora M
    Pol Tyg Lek; 1982 May; 37(12):339-40. PubMed ID: 6182556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.